低剂量人甲状旁腺激素1-34肽治疗骨质疏松症的初步试验。 - Suppr

Suppr

超能文献

Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.

作者信息

Reeve J, Tregear G W, Parsons J A

出版信息

Calcif Tissue Res. 1976 Aug;21 Suppl:469-77.

PMID:782668

Abstract

摘要

相似文献

Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.低剂量人甲状旁腺激素1-34肽治疗骨质疏松症的初步试验。

Calcif Tissue Res. 1976 Aug;21 Suppl:469-77.

A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.

Miner Electrolyte Metab. 1995;21(1-3):232-5.

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.重组人甲状旁腺激素1-34治疗男性和绝经后女性骨质疏松症的临床安全性述评

J Bone Miner Res. 2002 Jul;17(7):1151-61. doi: 10.1359/jbmr.2002.17.7.1151.

[Anabolic activity of parathyroid hormone: a new therapeutic perspective in primary osteoporosis].[甲状旁腺激素的合成代谢活性：原发性骨质疏松症的新治疗前景]

Ann Ital Med Int. 1987 Oct-Dec;2(4):321-6.

[Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].[人甲状旁腺激素（1-34）作为骨质疏松症的一种新型治疗药物]

Clin Calcium. 2005 Jan;15(1):18-24.

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.

Metab Bone Dis Relat Res. 1981;3(1):23-30. doi: 10.1016/s0221-8747(81)80019-7.

Parathyroid hormone (1-84) and treatment of osteoporosis.甲状旁腺激素（1-84）与骨质疏松症的治疗

Ann Pharmacother. 2005 Sep;39(9):1511-6. doi: 10.1345/aph.1G146. Epub 2005 Aug 2.

The potential of parathyroid hormone as a therapy for osteoporosis.甲状旁腺激素作为骨质疏松症治疗方法的潜力。

Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15.

Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis.

S Afr Med J. 2004 Mar;94(3):175-7.

Delivery of parathyroid hormone for the treatment of osteoporosis.甲状旁腺激素用于骨质疏松症的治疗。

Expert Opin Drug Deliv. 2005 Nov;2(6):993-1002. doi: 10.1517/17425247.2.6.993.

引用本文的文献

Increased PHOSPHO1 and alkaline phosphatase expression during the anabolic bone response to intermittent parathyroid hormone delivery.在间歇给予甲状旁腺激素时，骨合成反应中 PHOSPHO1 和碱性磷酸酶的表达增加。

Cell Biochem Funct. 2023 Mar;41(2):189-201. doi: 10.1002/cbf.3772. Epub 2022 Dec 20.

Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.甲状旁腺激素治疗通过改善Ⅰ型胶原的分布改善绝经后骨质疏松症妇女的皮质骨微观结构。

J Bone Miner Res. 2012 Mar;27(3):702-12. doi: 10.1002/jbmr.1497.

Parathyroid hormone analogues in the treatment of osteoporosis.甲状旁腺激素类似物在骨质疏松症治疗中的应用。

Nat Rev Endocrinol. 2011 Jul 12;7(11):647-56. doi: 10.1038/nrendo.2011.108.

Osteo-renal regulation of systemic phosphate metabolism.骨肾对全身磷代谢的调节。

IUBMB Life. 2011 Apr;63(4):240-7. doi: 10.1002/iub.437. Epub 2011 Mar 24.

Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.钙敏感受体负变构调节剂对甲状旁腺激素调节的药效动力学模型。

AAPS J. 2011 Jun;13(2):265-73. doi: 10.1208/s12248-011-9266-9. Epub 2011 Mar 25.

The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.甲状旁腺激素的骨生成作用：对骨质疏松症治疗的启示。

Drugs Aging. 1999 Aug;15(2):117-29. doi: 10.2165/00002512-199915020-00005.

Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.合成人甲状旁腺激素-（1-34）给药对骨质疏松症患者骨矿物质代谢的短期影响。

J Clin Invest. 1981 Nov;68(5):1261-71. doi: 10.1172/jci110372.

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.人甲状旁腺激素片段对绝经后骨质疏松症小梁骨的合成代谢作用：一项多中心试验。

Br Med J. 1980 Jun 7;280(6228):1340-4. doi: 10.1136/bmj.280.6228.1340.

A new method for calculating the accretion rate of bone calcium and some observations on the suitability of strontium-85 as a tracer for bone calcium.

Calcif Tissue Res. 1976 Apr 20(2):121-35. doi: 10.1007/BF02546402.

A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders.一种用于计算骨质疏松症及其他全身性骨骼疾病中骨形成和骨吸收速率的新示踪方法。

Calcif Tissue Res. 1976 Dec 22;22(2):191-206.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验